PLANNING STUDY Clause Samples

The PLANNING STUDY clause defines the requirements and procedures for conducting a preliminary analysis or assessment before the main project work begins. Typically, this clause outlines the scope of the study, the responsibilities of the parties involved, and the deliverables expected, such as reports or recommendations based on the findings. Its core function is to ensure that all parties have a clear understanding of the project's feasibility, risks, and requirements before committing significant resources, thereby reducing uncertainty and supporting informed decision-making.
PLANNING STUDY. 4.1 The Contractor shall prepare an implementation planning study in accordance with clause 15.6 of Part 1 of the Agreement. 1
View Source
PLANNING STUDY. 15.6.1 Within the time specified in the Order and prior to the commencement of a project to be implemented under a Contract, the Contractor must complete an implementation planning study. 15.6.2 The implementation planning study must meet the objectives specified in the Order which may include: (a) the Contractor’s assessment of the scope and complexity of the project; (b) required Deliverables; (c) resources required (including any resources to be made available by the Customer); (d) development of a Project Implementation and Payment Plan or a Service Level Agreement as relevant; or (e) any other requirements specified in the Order.
View Source
PLANNING STUDY. OCWD has retained a consultant to prepare a “Planning Study” to evaluate the Producers’ water systems, any of their Water Producing Facilities impacted by PFAS (“Impacted ▇▇▇▇▇”), and potential locations for construction of PFAS Treatment Systems for Impacted ▇▇▇▇▇. OCWD shall cause the consultant to actively consult with Producers in connection with preparation of the Planning Study. OCWD shall cause the consultant to provide a final Planning Study report to OCWD and Producers concurrently.
View Source
PLANNING STUDY. ▇▇▇▇▇▇ will conduct a conceptual design study with the ultimate goal of developing a project definition document for the ARFF Training Building for GOAA. A ROM cost estimate, based on the final concept, will be developed for use by GOAA for capital/project planning purposes.
View Source
PLANNING STUDY. The Engineer shall conduct a planning study that includes the development of improvement concepts to meet current roadway design standards as established by the latest editions of the State Roadway Design Manual, American Association of State Highway and Transportation Officials (AASHTO) Policy on Geometric Design of Highways and Streets, State Standard Specifications for Construction of Highways, Streets, and Bridges, Highway Capacity Manual – Transportation Research Board, AASHTO – A Policy on Design Standards Interstate System, and other associated State manuals, as applicable. The planning study is intended to: • Establish the need and purpose for the project. • Develop Environmental Constraints Map to characterize the environmental setting. • Develop and screen improvement options to determine which ones should be advanced for further detailed schematic design and environmental study. • Develop a preliminary (30%) schematic design layout of the ultimate roadway configuration. • Establish the right-of-way needs for the ultimate roadway configuration. The Engineer shall develop improvement concepts including: • Improvements shifted to either side of the current US 290 alignment in an effort to minimize impacts to existing and active development. • Review and analysis of intersection improvements with major cross roads (maximum of 6 intersections).
View Source

Related to PLANNING STUDY

  • Feasibility Study Buyer is granted the right to conduct engineering and/or market and economic feasibility studies of the Property and a physical inspection of the Property, including studies or inspections to determine the existence of any environmental hazards or conditions (collectively, the “Feasibility Study”) during the period (the “Feasibility Period”) commencing on the Effective Date and ending at 5:00 p.m., Central Time, on the June 3, 2010. With Seller’s permission, after Seller has received advance notice sufficient to permit it to schedule in an orderly manner Buyer’s examination of the Property and to provide at least 24-hours’ advance written notice to any affected tenants, Buyer or its designated agents may enter upon the Property during normal business hours for purposes of analysis or other tests and inspections which may be deemed necessary by Buyer for the Feasibility Study. Buyer or its designated representative must be accompanied by a designated representative of Seller or have received Seller’s written permission prior to entering upon the Property in connection with Buyer’s Feasibility Study; provided, however, Buyer may not enter into any space leased by any tenant without being accompanied by a designated representative of Seller. Seller agrees to make its representative reasonably available during normal business hours. Buyer will not alter the physical condition of the Property or conduct invasive testing without notifying Seller of its requested tests, and obtaining the written consent of Seller to any physical alteration of the Property or invasive testing. Buyer will utilize commercially reasonable diligence to conduct or cause to be conducted all inspections and tests in a manner and at times which will not unreasonably interfere with any tenant’s use and occupancy of the Property. If Buyer determines, in its sole judgment, that the Property is not suitable for any reason for Buyer’s intended use or purpose, or is not in satisfactory condition, then Buyer may terminate this Contract by written notice to Seller prior to expiration of the Feasibility Period, in which case the ▇▇▇▇▇▇▇ Money (other than the Option Money) will be returned to Buyer, and neither party shall have any further right or obligation hereunder other than as set forth herein with respect to rights or obligations which survive termination. If this Contract is not terminated pursuant to this Section 5(a), then after expiration of the Feasibility Period, after Seller has received advance notice sufficient to permit it to schedule in an orderly manner Buyer’s examination of the Property and to provide at least 24-hours’ advance written notice to any affected tenants, Buyer or its designated agents may enter upon the Property during normal business hours. Buyer or its designated representative must be accompanied by a designated representative of Seller or have received Seller’s written permission prior to entering upon the Property; provided, however, Buyer may not enter into any space leased by any tenant without being accompanied by a designated representative of Seller. If this Contract is not timely terminated pursuant to this Section 5(a), Buyer’s right to terminate this Contract pursuant to this Section 5(a) and any and all objections with respect to the Feasibility Study will be deemed to have been waived by Buyer for all purposes.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in ▇▇▇▇▇, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.